– Sophie Durand appointed Chief Executive Officer to guide Stellate Therapeutics towards clinical trials
– Investment from eureKARE to bring long-term expertise, financial and operational support
-EureKARE SA is a recently founded company focused on financing and building next generation biotechnology companies in the disruptive fields of the microbiome and synthetic biology. eureKARE is guided by influential founder, Alexandre Mouradian, along with a pan-European team led by renowned biotech expert Rodolphe Besserve.
– Biotech start-up studio model to select and nurture high quality European innovation with revolutionary potential to maximise opportunities for investors and scientists for the benefit of patients.
– eureKARE is guided by influential founder, Alexandre Mouradian, accompanied by a highly skilled team and an international Scientific Advisory Board of renowned experts